Nevertheless, while the PS19 model is based on a mutation linked to FTD, it remains relevant for studying certain aspects of 4R-tauopathies, as both patients with PSP and PS19 mice exhibit hyperphosphorylated 4R-tau leading to neurodegeneration [3]. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.